| Name | Adefovir dipivoxil |
|---|---|
| Synonyms |
Adefovir Impurity 3
9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine ADEFOVIR Ade Vove Adefovir dipivoxil 100 μg/mL in Acetonitrile ADEFOVIR PIVOXIL AdefovirDipivoxlMin Adefovir dipivoxil ADV 9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine Adefovir dipivoxil, >= Bis(Pivaloyloxymethyl)-9-[(R)-2-(Phosphonomethoxy)Ethyl]Adenine Hepsera Adefovir Dipivoxil (bis-POM PMEA), nucleotide analog reverse transcriptase inhibitor ADEFOVIR DIPVOXIL Adefovir DipivoxilQ: What is Adefovir Dipivoxil Q: What is the CAS Number of Adefovir Dipivoxil Q: What is the storage condition of Adefovir Dipivoxil Q: What e the applications of Adefovir Dipivoxil Preveon MFCD00869897 ADEFOVIR DIPIVOXIL ((((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)-bis(oxy))bis(methylene) bis(2,2-dimethy ADEFOVIR DIPIVOLIX Adefovir dipivoxil //BP Adefovir Dipivoxyl BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE Di(pivaloyloxymethyl) ester Adefovir Dipivoxil > Adefovir Dipivoxi Hsera|||GS 0840|||Preveon Adefovir Dipivoxl 1,1'-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)]-2,2-dimethyl-propanoic acid ester Hsera BIS POM PMEA Adefovir dipivoxil,9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine 2,2-DiMethyl-propanoic Acid 1,1'-[[[[2-(6-Amino-9H-purin-9-yl)ethoxy]Methyl]phosphinylidene]bis(oxyMethylene)] Ester adefuweizhi GS 0840 Adefovir Dipivoxil API EINECS 200-001-8 Adefovir dipivoxil - Bio-X Propanoic acid, 2,2-dimethyl-, 1,1'-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)] ester ((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate) Adefovir dipivoxil, 10 mM in DMSO BIS-POM PMEA; PREVEON; HSERA 9-[2-[bis[(pivaloyloxy)methoxy]phosphinyl]methoxy]ethyl]adenine Adefovir Dipivoxil Tablets Adefovir Dipivoxil(Preveon, Hsera) 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3-phosphanon-1-yl pivalate (non-preferred |
| Description | Adefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body.Target: NRTIs; HBVAdefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body. Adefovir Dipivoxil is used for treatment of hepatitis B and herpes simplex virus infection [1-3]. Adefovir Dipivoxil is approved for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (primarily ALT) or histologically active disease. Adefovir Dipivoxil is a failed treatment for HIV[3, 4]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 641.0±65.0 °C at 760 mmHg |
| Melting Point | 98-102ºC |
| Molecular Formula | C20H32N5O8P |
| Molecular Weight | 501.470 |
| Flash Point | 341.5±34.3 °C |
| Exact Mass | 501.198853 |
| PSA | 176.79000 |
| LogP | 2.45 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.569 |
| Storage condition | −20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H332 |
| Precautionary Statements | P280 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi |
| Risk Phrases | R20/21/22 |
| Safety Phrases | 36/37 |
| RIDADR | NONH for all modes of transport |
|
~75%
142340-99-6 |
| Literature: WO2010/110506 A1, ; Page/Page column 7 ; |
|
~%
142340-99-6 |
| Literature: WO2007/13085 A1, ; Page/Page column 10-11 ; |
|
~%
142340-99-6 |
| Literature: European Journal of Medicinal Chemistry, , vol. 63, p. 869 - 881 |
|
~%
142340-99-6 |
| Literature: EP2330107 A2, ; Page/Page column 6 ; |
|
~%
142340-99-6 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 25 p. 4958 - 4965 |
|
~%
142340-99-6 |
| Literature: Journal of Medicinal Chemistry, , vol. 39, # 25 p. 4958 - 4965 |
|
~%
142340-99-6 |
| Literature: US2012/238753 A1, ; |
|
~%
142340-99-6 |
| Literature: US2012/238753 A1, ; |
|
~%
142340-99-6 |
| Literature: European Journal of Medicinal Chemistry, , vol. 63, p. 869 - 881 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |